Inventor · disambiguated record
Ofer Levy
Also filed as: LEVY OFER
31 granted patents·34 pending applications·52 citations·filing 1999–2025
95Inventor score
Files withCOMPUGEN LTD17CHILDRENS MEDICAL CENTER13LEVY OFER4MELLANOX TECHNOLOGIES LTD4DANA FARBER CANCER INST INC3
Top patents by PatentIndex Score
65 records- 0186US2025322981A1Multi-cable interconnect connection systemMELLANOX TECHNOLOGIES LTD·Filed 2025·Application pending·0 cites
- 0285US8415455B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsLEVINE ZURIT·Filed 2008·Granted Apr 9, 2013·9 cites·14 claims
- 0384US9107862B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Aug 18, 2015·5 cites·9 claims
- 0483US8529943B2Angiopoietin derived peptidesKLIGER YOSSEF·Filed 2009·Granted Sep 10, 2013·10 cites·17 claims
- 0581US9375466B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Jun 28, 2016·3 cites·4 claims
- 0681US2024025973A1Pvrig polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 0778US10550173B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2016·Granted Feb 4, 2020·2 cites·10 claims
- 0876US6376465B1Therapeutic uses of BPI protein products in BPI-deficient humansXOMA TECHNOLOGY LTD·Filed 2000·Granted Apr 23, 2002·5 cites·9 claims
- 0975US11673891B2Imidazopyrimidine compounds and uses thereofDANA FARBER CANCER INST INC·Filed 2018·Granted Jun 13, 2023·1 cites·19 claims
- 1074US12367992B2Multi-cable interconnect connection systemMELLANOX TECHNOLOGIES LTD·Filed 2022·Granted Jul 22, 2025·0 cites·20 claims
- 1173US11655297B2ILDR2 antagonists and combinations thereofBAYER AG·Filed 2018·Granted May 23, 2023·1 cites·18 claims
- 1273US10098934B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Oct 16, 2018·1 cites·9 claims
- 1372US10731129B2Methods of evaluating immunogenicity of an agent using an artificial tissue constructCHILDRENS MEDICAL CENTER·Filed 2013·Granted Aug 4, 2020·1 cites·6 claims
- 1472US2024287174A1Hide1 compositions and methodsCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 1571US12268739B2Use of toll-like receptor 2 (TLR-2) agonist for modulating human immune responseCHILDRENS MEDICAL CENTER·Filed 2019·Granted Apr 8, 2025·1 cites·18 claims
- 1670US11795209B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2020·Granted Oct 24, 2023·0 cites·15 claims
- 1770US2025325659A1Use of toll-like receptor 2 (tlr-2) agonist for modulating human immune responseCHILDRENS MEDICAL CENTER·Filed 2024·Application pending·0 cites
- 1869US2011311450A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsLEVINE ZURIT·Filed 2009·Application pending·0 cites
- 1967US10881729B2Vaccine adjuvant compositionsCHILDRENS MEDICAL CENTER·Filed 2015·Granted Jan 5, 2021·1 cites·16 claims
- 2066US8575107B2Clusterin derived peptideKLIGER YOSSEF·Filed 2009·Granted Nov 5, 2013·0 cites·6 claims
- 2166US7041644B2Therapeutic uses of BPI protein products in BPI-deficient humansXOMA TECHNOLOGY·Filed 2002·Granted May 9, 2006·1 cites·22 claims
- 2263US2018298109A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2018·Application pending·0 cites
- 2361US9538852B2Stabilizing apparatus for inclined legsLEVY OFER·Filed 2012·Granted Jan 10, 2017·8 cites·27 claims
- 2460US2008193468A1Method for Stimulating the Immune Response of NewbornsCHILDRENS MEDICAL CENTER·Filed 2005·Application pending·0 cites
- 2558US12069829B2Dual connect switch moduleMELLANOX TECHNOLOGIES LTD·Filed 2021·Granted Aug 20, 2024·0 cites·23 claims
- 2658US2017037141A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 2757US2011052501A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsDASSA LIAT·Filed 2009·Application pending·0 cites
- 2857US2006252688A1Therapeutic uses of BPI protein products in BPI-deficient humansLEVY OFER·Filed 2006·Application pending·0 cites
- 2956US2024148864A1Polysaccharide adjuvants for virus vaccinesCHILDRENS MEDICAL CENTER·Filed 2022·Application pending·0 cites
- 3056US2016068606A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2015·Application pending·0 cites
- 3155US11633473B2Stimulator of Interferon Genes (STING) ligands and uses thereofCHILDRENS MEDICAL CENTER·Filed 2018·Granted Apr 25, 2023·0 cites·17 claims
- 3255US2017107284A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 3355US2025041278A1Tlr8 agonist for modulating immune responseCHILDRENS MEDICAL CT CORP·Filed 2022·Application pending·0 cites
- 3455US2025000971A1Tlr4 agonist for modulating immune responseCHILDRENS MEDICAL CT CORP·Filed 2022·Application pending·0 cites
- 3554US8512708B2GP96 derived peptidesKLIGER YOSSEF·Filed 2009·Granted Aug 20, 2013·0 cites·4 claims
- 3654US2016272707A1Vstm5 antibodies, and uses thereof for treatment of cancer, infectious diseases and immune related diseasesCOMPUGEN LTD·Filed 2014·Application pending·0 cites
- 3754US2023407158A1A dust control substances-solution and how it is to be appliedNANO Z COATING LTD·Filed 2021·Application pending·0 cites
- 3853US12155979B2Cable pillar for director switch systemsMELLANOX TECHNOLOGIES LTD·Filed 2022·Granted Nov 26, 2024·0 cites·20 claims
- 3953US9255132B2Angiopoietin derived peptidesCOMPUGEN LTD·Filed 2013·Granted Feb 9, 2016·0 cites·27 claims
- 4052US9770484B2BPI and its congeners as radiation mitigators and radiation protectorsDANA FARBER CANCER INST INC·Filed 2016·Granted Sep 26, 2017·0 cites·18 claims
- 4152US2024115693A1Sars-cov-2 antigen nanoparticles and uses there ofCHILDRENS MEDICAL CENTER·Filed 2022·Application pending·0 cites
- 4250US9884089B2BPI and its congeners as radiation mitigators and radiation protectorsDANA FARBER CANCER INST INC·Filed 2016·Granted Feb 6, 2018·0 cites·21 claims
- 4349US2023201340A1Adjuvants for severe acute respiratory syndrome-related coronavirus (sars-cov) vaccinesCHILDRENS MEDICAL CENTER·Filed 2021·Application pending·0 cites
- 4449US2022169736A1Combinations of anti-ildr2 antibodies and pd-1 antagonistsBAYER AG·Filed 2020·Application pending·0 cites
- 4549US2023310438A1Tlr7/8 agonists to enhance immune responses in opioid using individualsCHILDRENS MEDICAL CENTER·Filed 2020·Application pending·0 cites
- 4649US2013315819A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Application pending·0 cites
- 4748US2018305451A1Hide1 compositions and methodsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 4848US2023201339A1Use of thiazole amide compounds for modulating human immune responseCHILDRENS MEDICAL CENTER·Filed 2020·Application pending·0 cites
- 4947US2015001309A1Drip irrigator and irrigation system comprising the sameLEVY IDO·Filed 2014·Application pending·0 cites
- 5046US10507045B2Facet distraction and fusion prosthesisZYGOFIX LTD·Filed 2017·Granted Dec 17, 2019·0 cites·9 claims
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ofer Levy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →